The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The new rule, which was proposed by the administration on Tuesday, would dramatically expand access to anti-obesity ...
The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback